Informações:
Falhas:
ID
14000
Descrição
Crizotinib Plus Pembrolizumab In Alk-positive Advanced Non Small Cell Lung Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02511184
Link
https://clinicaltrials.gov/show/NCT02511184
Palavras-chave
Versões (1)
- 21/03/2016 21/03/2016 -
Transferido a
21 de março de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility ALK-positive Advanced NSCLC NCT02511184
Eligibility ALK-positive Advanced NSCLC NCT02511184
- StudyEvent: Eligibility
Similar models
Eligibility ALK-positive Advanced NSCLC NCT02511184
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Non-Small Cell Lung Carcinoma
Item
histologically or cytologically proved diagnosis of locally advanced recurrent or metastatic non-squamous nsclc that is not suitable for local curative treatment.
boolean
C0007131 (UMLS CUI [1])
Alk-positive nsclc
Item
alk-positive nsclc as determined by a test that is approved or validated for use as a companion diagnostic test.
boolean
C3888914 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,2])
Neoplasm Metastasis
Item
no prior systemic therapy for metastatic disease.
boolean
C0027627 (UMLS CUI [1])
Adjuvant chemotherapy
Item
adjuvant chemotherapy more than 12 months prior to study enrollment.
boolean
C0085533 (UMLS CUI [1])
Measurable Disease
Item
Measurable disease as per recist 1.1
boolean
C1513041 (UMLS CUI [1])
ECOG
Item
Ecog ps 0 or 1.
text
C1520224 (UMLS CUI [1])
ALK receptor tyrosine kinase assay
Item
prior exposure to alk receptor tyrosine kinase inhibitor, anti-pd1, anti-pdl1 or any drug targeting t-cell checkpoint pathways.
boolean
C3203742 (UMLS CUI [1])
Immunologic Deficiency Syndromes
Item
Known diagnosis of immunodeficiency or is receiving systemic steroid therapy or other form of immunosuppressive therapy within 7 days of clinical trial treatment.
boolean
C0021051 (UMLS CUI [1])
C4039704 (UMLS CUI [2])
C4039704 (UMLS CUI [2])
Autoimmune Diseases
Item
Active autoimmune disease that has required systemic treatment in the past 3 months.
boolean
C0004364 (UMLS CUI [1])
Lung Diseases
Item
history of extensive disseminated interstitial fibrosis or any grade of interstitial lung disease.
boolean
C0206062 (UMLS CUI [1])